High soluble CD30, CD25, and IL-6 may identify patients with worse survival in CD30+ cutaneous lymphomas and early mycosis fungoides.
about
Mycosis fungoides and Sézary syndrome: Current challenges in assessment, management and prognostic markers.Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?Peripheral T-cell and NK cell lymphoproliferative disorders: cell of origin, clinical and pathological implications.Prognostic factors and risk stratification in early mycosis fungoides.Multiple cytokine-producing primary cutaneous anaplastic large cell lymphoma.
P2860
High soluble CD30, CD25, and IL-6 may identify patients with worse survival in CD30+ cutaneous lymphomas and early mycosis fungoides.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
High soluble CD30, CD25, and I ...... s and early mycosis fungoides.
@ast
High soluble CD30, CD25, and I ...... s and early mycosis fungoides.
@en
type
label
High soluble CD30, CD25, and I ...... s and early mycosis fungoides.
@ast
High soluble CD30, CD25, and I ...... s and early mycosis fungoides.
@en
prefLabel
High soluble CD30, CD25, and I ...... s and early mycosis fungoides.
@ast
High soluble CD30, CD25, and I ...... s and early mycosis fungoides.
@en
P2093
P2860
P356
P1476
High soluble CD30, CD25, and I ...... s and early mycosis fungoides.
@en
P2093
Eric C Vonderheid
Igor Y Pavlov
Julio C Delgado
Marshall E Kadin
P2860
P2888
P304
P356
10.1038/JID.2011.351
P407
P433
P577
2011-11-10T00:00:00Z
P5875
P6179
1024786949